Skip to main content
PLOS One logoLink to PLOS One
. 2026 Oct 27;21(10):e0361327. doi: 10.1371/journal.pone.0361327

Airway management and anaesthetic interventions for children with cleft lip and/or palate undergoing general anaesthesia: Protocol for a systematic review and meta-analysis

Sharmin Akter Sumi 1, Kazi Mahzabin Arin 2,*, Shahriar Mohd Shams 3, Tanzila Rafique 3, Keertika Orchi 4, Arna Chowdhury 4, Mohammad Meshbahur Rahman 5, Md Atiqul Haque 4
Editor: Silvia Fiorelli6
PMCID: PMC13712514  PMID: 42945279

Abstract

Background

Children with cleft lip and/or palate may present unique challenges during perioperative airway management because of altered upper-airway and craniofacial anatomy. These children frequently undergo surgical procedures requiring general anaesthesia and airway instrumentation. Several airway-management and anaesthetic techniques have been evaluated to facilitate tracheal intubation and reduce perioperative airway complications, but the comparative evidence from randomised controlled trials has not been systematically evaluated.

Methods

This systematic review and meta-analysis will include randomised controlled trials involving children < 18 years with cleft lip and/or palate undergoing general anaesthesia. Eligible studies will compare alternative techniques or devices for airway management or other anaesthetic strategies between two groups of cleft lip/palate patients. The primary outcome will be difficulty in tracheal intubation. Where definitions vary substantially, outcomes will be analysed separately or synthesised narratively. Secondary outcomes will include difficult mask ventilation, oxygen desaturation, airway obstruction, difficult laryngoscopy, first-attempt intubation success, number of intubation attempts, time to successful intubation or airway establishment, failed intubation and other perioperative airway or respiratory adverse events. Two reviewers will independently select RCTs, extract data and assess risk of bias. Risk of bias will be evaluated using the Cochrane Risk of Bias 2 tool. Random-effects meta-analysis will be performed where clinically appropriate. Risk ratios will be used for dichotomous outcomes and mean differences or standardized mean differences for continuous outcomes. Certainty of evidence for important outcomes will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

Registration and review status

The review was prospectively registered in PROSPERO on 10 March 2026 (CRD420261326076). Full-text screening and data extraction are ongoing and not yet complete. Protocol amendments are documented transparently in PROSPERO.

Introduction

Cleft lip and/or palate are among the most common congenital craniofacial anomalies worldwide and result from disruption of normal fusion of facial structures during embryonic development [1,2]. Affected children display substantial variation in maxillary, palatal, nasal and midfacial anatomy. These anatomical characteristics may influence upper-airway configuration and have important implications when general anaesthesia and airway instrumentation are required.

Children with cleft lip and/or palate commonly undergo several surgical procedures during infancy and childhood, including cleft lip repair, palatoplasty, alveolar bone grafting and secondary reconstructive procedures. Consequently, some children experience repeated exposure to general anaesthesia and airway management. Airway management in young children is already physiologically demanding because of smaller airway dimensions, reduced oxygen reserves and rapid desaturation. Altered oral and craniofacial anatomy associated with cleft conditions may further complicate mask ventilation, laryngoscopy, tracheal intubation and maintenance of a secure airway [3–5].

Different approaches have therefore been investigated to improve airway management during cleft surgery. Randomised trials have compared, among other strategies, hard-gum-shield-assisted versus paraglossal intubation [6], Airway Scope versus Macintosh laryngoscopy [7], videolaryngoscopic versus direct paraglossal laryngoscopy [8], and different preformed endotracheal tube designs [9]. Outcomes evaluated across these trials include intubation time, first-attempt success, laryngoscopic view, intubation difficulty, need for external laryngeal manipulation, tube exchange, oxygen desaturation and airway-related complications. However, variation in interventions and outcome definitions makes individual trial findings difficult to translate into an overall evidence-based approach.

Recent systematic reviews have synthesized observational evidence concerning pharyngeal airway dimensions in individuals with cleft lip and palate [10,11]. These reviews improve understanding of structural airway differences but address a question distinct from the comparative effectiveness and safety of airway-management and anaesthetic interventions. For example, a recent meta-analysis of 39 studies focused primarily on pharyngeal airway volumes and cross-sectional dimensions rather than randomised airway-management strategies [10]. Therefore, a systematic evaluation focused specifically on randomised intervention evidence remains clinically relevant. Relevant craniofacial or airway anatomical features reported in eligible trials will be presented as participant baseline characteristics or potential effect modifiers rather than independent primary outcomes.

The primary objective of this systematic review and meta-analysis is to assess the comparative effectiveness of airway management and anaesthetic interventions for tracheal intubation in paediatric patients with cleft lip and/or palate undergoing general anaesthesia. Secondary objectives are to evaluate first-attempt intubation success, difficult laryngoscopy, intubation time, difficult mask ventilation and other perioperative airway or respiratory adverse event outcomes.

Methods

Study design and reporting framework

This is a protocol for systematic review and meta-analysis of randomised controlled trials. The protocol will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2015 statement [12]. The completed systematic review and meta-analysis will be reported according to the PRISMA 2020 statement [13]. The review is prospectively registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD420261326076) on 10 March 2026. The registered review start date was 1 May 2026. All studies meeting the predetermined eligibility criteria will be considered for inclusion.

Protocol amendments

Following registration in PROSPERO and during methodological refinement of the review, the eligibility criteria were clarified to include only randomised controlled trials. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was added to assess the certainty of evidence. These amendments were made before quantitative evidence synthesis and were not based on the magnitude, direction or statistical significance of pooled treatment effects. All substantive amendments will be dated, justified and updated in the PROSPERO record and will be reported transparently in the completed systematic review.

Review question

The review will address the following question:

In children aged up to 18 years with cleft lip and/or palate undergoing general anaesthesia, what is the comparative effectiveness and safety of different airway-management or anaesthetic interventions?

Eligibility criteria

Population.

Eligible studies will include children aged up to 18 years diagnosed with cleft lip, cleft palate, or cleft lip-palate who undergo a surgical or procedural intervention requiring general anaesthesia and airway management.

In accordance with the registered protocol, studies focusing primarily on preterm infants or on major syndrome or developmental craniofacial disorders other than cleft lip and/or palate will be excluded unless relevant data for the eligible cleft population can be extracted separately.

Interventions.

Primary domain: airway-management interventions

Secondary: associated anaesthetic strategies affecting airway outcomes.

Comparators.

Eligible comparators will include usual or conventional airway management, another airway-management technique or device, or an alternative anaesthetic strategy evaluated within the randomised trial.

Study design.

Only randomised controlled trials will be included.

Publication characteristics.

Peer-reviewed full-text studies published in English will be eligible. The registered search period begins on 1 January 2001. The final search will therefore cover 1 January 2001 to the date of the final search update.

Outcomes

Primary outcome.

The primary outcome will be difficult tracheal intubation, as defined by the investigators in each eligible trial. If difficult intubation cannot be pooled due to inconsistent definitions, first-attempt success and number of attempts will be considered supportive outcomes. Where available, the definition or grading system used to classify intubation difficulty will be recorded, including number of attempts, Intubation Difficulty Score, investigator-defined difficulty, or failed tracheal intubation.

Secondary outcomes.

Secondary outcomes will include first-attempt or first-pass intubation success; failed tracheal intubation; difficult laryngoscopy; Cormack-Lehane or comparable laryngoscopic grade; number of intubation attempts; time to successful tracheal intubation or airway establishment; requirement for external laryngeal manipulation or additional airway manoeuvres; difficult or failed mask ventilation; tracheal-tube exchange or displacement where applicable; oxygen desaturation or hypoxaemia; airway obstruction; laryngospasm; bronchospasm; aspiration; airway, oral or oropharyngeal trauma; postoperative airway morbidity; and other clearly defined perioperative airway or respiratory adverse events.

Relevant baseline anatomical features, including cleft phenotype, micrognathia or other reported airway-related craniofacial characteristics, will be extracted as participant characteristics and considered as potential sources of clinical heterogeneity where sufficient information is available.

Information sources

Electronic database searches were conducted in the Cochrane Library, Embase, PubMed, Scopus, Web of Science and Google Scholar for studies published from 1st January 2001–31st May 2026. To identify relevant registered, ongoing or completed randomised controlled trials, ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform were searched. Backward and forward citation searching was also performed on the included studies.

Search strategy

The search strategy combined controlled vocabulary and free-text terms representing four concepts: cleft lip/palate, airway management or anaesthesia, children, and randomised controlled trials. Table 1 presents the detailed search terms and Medical Subject Heading (MeSH) strategies used across the databases.

Table 1. Search term strategies using keywords and Medical Subject Heading (MeSH) terms.

Keywords MeSH Terms
anesthetic implications (Anaesthetic implication) OR (anaesthetic complication) OR (anaesthetic management) OR (Preoperative Care) OR (Postoperative Complications)
airway (Airway) OR (upper airway) OR (airway instrumentation) OR (airway obstruction) OR (airway instrumentation) OR (airway adverse effect) OR (airway adverse events) OR (airway management)
craniofacial anatomy (Craniofacial) OR (Anatomical abnormalities) OR (craniofacial abnormalities) OR (craniofacial anomalies) OR (Maxillofacial Abnormalities)
cleft lip & cleft palate (Cleft lip palate) OR (Cleft lip-palate) OR (cleft lip/palate) OR (cleft lip) OR (cleft palate) OR (orofacial cleft)
children (newborn) OR (infant) OR (preschool Child) OR (paediatrics) OR (adolescent)

The strategy was adapted to the syntax and indexing requirements of each database. Search strategies, final search dates and numbers of records retrieved from each database will be reported in the completed review.

Data management

Search results will be imported into Rayyan for record management, deduplication and screening. Microsoft Excel will be used for structured data extraction. Separate files or worksheets will be maintained for study identification, eligibility decisions, reasons for full-text exclusion, extracted study characteristics, outcome data and risk-of-bias judgments. Version-controlled copies of the extraction file will be retained to preserve an audit trail of changes made during the review.

Study selection

Two reviewers will screen titles and abstracts independently following the prespecified eligibility criteria. Studies considered potentially eligible, or for which eligibility cannot be confirmed from the title and abstract, will undergo full-text assessment by two reviewers independently. Full-text eligibility decisions will be based exclusively on the prespecified population, intervention, comparator and study-design criteria. The reasons for exclusion will be recorded at the full-text stage. Disagreements will be resolved through discussion and consensus. Where consensus cannot be reached, a third reviewer will adjudicate. The completed review will report on the study-selection process using a PRISMA flow diagram.

Data extraction

A standardized Microsoft Excel data-extraction form will be used and pilot tested before completion of extraction. Data extraction will be performed independently and in duplicate. Extraction responsibilities may be distributed among four reviewers, but each eligible study will be evaluated by two reviewers independently. Disagreements will be resolved through discussion or consultation with a third reviewer.

The following information will be extracted where available: publication details; country and clinical setting; study design; recruitment period; sample size; participant age, sex and cleft phenotype; relevant baseline craniofacial or airway characteristics; surgical procedure; intervention characteristics; comparator characteristics; anaesthetic induction and maintenance techniques; airway device or intubation method; definitions and measurement methods for outcomes; duration of follow-up where relevant; numerical outcome data; adverse events; funding or sponsorship of the individual trial where reported; and information needed for risk-of-bias assessment.

Missing or unclear information

The review will primarily use information available from published articles, supplementary files and trial-registry records. In accordance with the registered protocol, study authors will not routinely be contacted to obtain additional information. Missing or unclear information will be documented and considered during risk-of-bias assessment and interpretation of the evidence.

Where statistical information such as standard deviations is not reported but can be derived from other available statistics using established methods, appropriate calculations described in the Cochrane Handbook will be considered [14].

Risk of bias assessment

Two reviewers will assess risk of bias independently using the Cochrane Risk of Bias 2 tool. The assessment will consider bias arising from the randomisation technique, any deviation from the intended interventions, missing data and selection of the reported result. Each relevant result will be categorized as having low risk of bias, some concerns, or high risk of bias in accordance with RoB 2 guidance. Disagreements will be resolved through discussion or adjudication by a third reviewer. Because only randomised controlled trials will be included in the final review, ROBINS-I and JBI critical-appraisal tools will not be used.

Data synthesis

A structured narrative synthesis will be presented for all eligible studies. Meta-analysis will be undertaken only when at least two studies are sufficiently comparable with respect to participants, interventions, comparators and outcome definitions. Studies evaluating clinically distinct intervention classes will not be pooled merely because they report the same outcome.

For dichotomous outcomes, including difficult intubation, first-attempt success, failed intubation and adverse events, treatment effects will generally be expressed as risk ratios with 95% confidence intervals. For continuous outcomes, such as intubation time, mean differences with 95% confidence intervals will be calculated when the same measurement scale is used. Standardized mean differences will be considered when studies measure the same underlying construct using different scales.

Random-effects meta-analysis will be used as the primary synthesis model where quantitative pooling is appropriate because variation in patient age, cleft phenotype, surgical procedures, airway techniques and anaesthetic interventions is anticipated. Between-study variance will preferably be estimated using restricted maximum likelihood methods. Where quantitative synthesis is inappropriate because of insufficient studies or substantial clinical or methodological diversity, findings will be summarized narratively and presented in structured tables. Statistical heterogeneity will be assessed using the I² statistic and τ² estimate, and clinical and methodological heterogeneity will be considered when interpreting pooled effects. Analyses will be conducted using established meta-analysis software such as Review Manager and/or R. The exact software and version will be reported in the completed review.

Because eligible trials are expected to compare heterogeneous airway techniques and devices (for example, videolaryngoscopy versus direct laryngoscopy, or different laryngoscope designs), trials will be pooled only when interventions, comparators and outcome definitions are sufficiently similar. Trials without a shared comparator will not be combined, and network meta-analysis will not be undertaken because the evidence network is expected to be sparse. Time to intubation will be interpreted together with success-related outcomes (first-attempt success, number of attempts and failed intubation) and airway complications, which will be tabulated side by side for each comparison; a shorter intubation time will not be regarded as beneficial if it is accompanied by lower success or more complications.

Unit-of-analysis considerations

For conventional parallel-group randomised trials, the individual participant will be the unit of analysis. For trials containing more than two relevant intervention groups, eligible arms will be included while avoiding double counting of shared comparator participants. Where necessary, comparator groups may be divided, or intervention groups may be combined according to established Cochrane methods [14].

Trials with zero events in both intervention groups will be described but will not contribute directly to conventional relative effect estimates where these cannot be calculated.

Subgroup analyses

Where sufficient numbers of clinically comparable trials are available, exploratory subgroup analyses may be undertaken according to age group, cleft phenotype, type of cleft surgery, and category of airway-management or anaesthetic intervention. Subgroup analyses will only be undertaken where adequate data are available and will be interpreted cautiously because such analyses may have limited statistical power. Meta-regression is not prespecified because the number of eligible randomised trials is expected to be limited.

Sensitivity analyses

When sufficient studies are accessible, we will conduct sensitivity analyses to evaluate the robustness of the findings. These may include exclusion of trials assessed as high risk of bias and assessing the effect of alternative reasonable analytical assumptions. Sensitivity analyses must be interpreted with caution, particularly when the meta-analysis is based on a limited number of trials.

Assessment of reporting bias

If at least 10 sufficiently comparable randomised trials contribute to a meta-analysis, funnel plots will be examined for potential small-study effects. Where appropriate, we will consider a statistical test of funnel-plot asymmetry, such as Egger’s test. We will not interpret funnel-plot asymmetry as publication bias without considering other clinical and methodological explanations.

Certainty of evidence

We will assess the certainty of evidence for the primary and secondary outcomes using the Grading of Recommendations Assessment, Development and Evaluation approach (GRADE) [15].

Randomised trial evidence will initially be considered high certainty and may be rated down because of risk of bias, inconsistency or publication bias. Certainty will be categorized as high, moderate, low or very low. A Summary of Findings table will be prepared for the comparisons where appropriate.

Review status and timeline

The systematic review was registered prospectively in PROSPERO on 10 March 2026 (CRD420261326076), before the registered review start date of 1 May 2026. At the time of preparation of this revised protocol, full-text screening and data extraction are ongoing and have not been completed.

No quantitative evidence synthesis or meta-analysis has yet been performed, and no pooled review results have been generated. The registered review timeline specifies 31 August 2026 as the anticipated review end date. Data extraction is currently expected to be completed by approximately this date, with evidence synthesis and preparation of the completed systematic review to follow. Any change to the anticipated completion timeline will be updated in PROSPERO.

Ethics and dissemination

This review will collect data from published studies and will not involve direct recruitment of human participants, collection of identifiable personal information, or assignment to a new intervention. Therefore, this systematic review does not require institutional ethics approval or individual informed consent. The findings will be submitted to a peer-reviewed journal for publication and disseminated through scientific seminars and academic presentations.

Discussion

Children with cleft lip and/or palate increase the complexity of perioperative airway and anaesthetic management due to the anatomical variation and repeated surgical procedures. Although several randomised trials have evaluated different airway-management devices, intubation approaches, endotracheal tubes and anaesthetic strategies, the clinical literature remains fragmented across different interventions and outcome measures.

The proposed systematic review will focus specifically on randomised controlled trial evidence, allowing a more direct assessment of comparative intervention effects than would be possible from observational studies alone. Restricting the review to randomised trials is also expected to provide a more methodologically coherent evidence base for evaluating intervention effectiveness and safety.

Airway management in children with cleft lip and/or palate is clinically important because successful, smooth airway establishment is essential for safe surgery and preventing perioperative airway adverse events. The anatomical variations associated with cleft lip and/or palate, including altered oral cavity structures, palatal defects and potential differences in airway anatomy, may influence the effectiveness and safety of commonly used airway management techniques. Although several devices and approaches have been introduced to improve intubation success rate and reduce airway-related complications, anaesthesiologists currently rely on evidence from individual trials with varying interventions. A systematic synthesis of randomised evidence is therefore needed to clarify the comparative benefits and potential limitations of available airway-management and anaesthetic strategies, supporting more evidence-informed decision-making in airway management in children with cleft lip and/or palate.

The review nevertheless has anticipated limitations. The number of eligible randomised trials may be small, interventions may be clinically diverse, and definitions of difficult intubation, intubation success and airway complications may vary among studies. These factors may limit the number of outcomes for which quantitative synthesis is appropriate. Language restriction to English and the registered publication-date restriction beginning in 2001 may also introduce selection limitations. These limitations will be considered when interpreting the findings and when evaluating certainty of evidence.

The review is expected to identify which airway-management and anaesthetic interventions have been tested in randomised trials, and clarify their comparative effectiveness on airway anaesthetic management outcomes.

Supporting information

S1 Checklist. PRISMA-P 2015 checklist.

(DOCX)

pone.0361327.s001.docx (19.8KB, docx)

Acknowledgments

The authors acknowledge the assistance of the icddr,b Library in supporting the literature search.

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Salari N, Darvishi N, Heydari M, Bokaee S, Darvishi F, Mohammadi M. Global prevalence of cleft palate, cleft lip and cleft palate and lip: A comprehensive systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2022;123(2):110–20. doi: 10.1016/j.jormas.2021.05.008 [DOI] [PubMed] [Google Scholar]
  • 2.Babai A, Irving M. Orofacial clefts: Genetics of cleft lip and palate. Genes (Basel). 2023;14(8):1603. doi: 10.3390/genes14081603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Denning S, Ng E, Wong Riff KWY. Anaesthesia for cleft lip and palate surgery. BJA Educ. 2021;21(10):384–9. doi: 10.1016/j.bjae.2021.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Disma N, Asai T, Cools E, Cronin A, Engelhardt T, Fiadjoe J, et al. Airway management in neonates and infants: European Society of Anaesthesiology and Intensive Care and British Journal of Anaesthesia joint guidelines. Br J Anaesth. 2024;132(1):124–44. doi: 10.1016/j.bja.2023.08.040 [DOI] [PubMed] [Google Scholar]
  • 5.Desalu I, Adeyemo W, Akintimoye M, Adepoju A. Airway and respiratory complications in children undergoing cleft lip and palate repair. Ghana Med J. 2010;44(1):16–20. doi: 10.4314/gmj.v44i1.68851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mahmoud AAA, Fouad AZ, Mansour MA, Kamal AM. A novel intubation technique in bilateral cleft palate pediatric patients: Hard gum shield-aided intubation. Paediatr Anaesth. 2013;23(4):349–54. doi: 10.1111/pan.12080 [DOI] [PubMed] [Google Scholar]
  • 7.Okumura Y, Okuda M, Sato Boku A, Tachi N, Hashimoto M, Yamada T, et al. Usefulness of Airway Scope for intubation of infants with cleft lip and palate-comparison with Macintosh laryngoscope: A randomized controlled trial. BMC Anesthesiol. 2019;19(1):12. doi: 10.1186/s12871-018-0678-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ray A, Sen IM, Bhardwaj N, Yaddanapudi S, Mathews P. Videolaryngoscopic versus direct laryngoscopic paraglossal intubation for cleft lip/palate reconstructive surgeries: A randomised controlled trial. Indian J Anaesth. 2021;65(8):593–9. doi: 10.4103/ija.ija_463_21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kamaladevi RK, Mishra SK, Rudingwa P, Mohapatra DP, Badhe AS, Senthilnathan M. Comparison of preformed microcuff and preformed uncuffed endotracheal tubes in pediatric cleft palate surgery-A randomized controlled trial. Paediatr Anaesth. 2024;34(4):340–6. doi: 10.1111/pan.14837 [DOI] [PubMed] [Google Scholar]
  • 10.Ahrari F, Eslami N, Bardideh E, Ghorbani M, Forghani M, Gazerani A. Comparison of pharyngeal airway dimensions between nonsyndromic cleft lip and palate patients and healthy controls: A systematic review and meta-analysis. Cleft Palate Craniofac J. 2026;63(5):1373–84. doi: 10.1177/10556656251325095 [DOI] [PubMed] [Google Scholar]
  • 11.Rai S, Debnath P, Deb Barma M, Majumder P, Paul M, Bhattacharjee A. CBCT analysis of pharyngeal airway dimensions in cleft lip and palate: A systematic review and meta-analysis. Natl J Maxillofac Surg. 2026;17(2):199–212. doi: 10.4103/njms.njms_9_25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;349(jan02 1):g7647–g7647. doi: 10.1136/bmj.g7647 [DOI] [PubMed] [Google Scholar]
  • 13.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. Version 6.5. Cochrane; 2024. [Google Scholar]
  • 15.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6. doi: 10.1136/bmj.39489.470347.AD [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Silvia Fiorelli

16 Sep 2026

Dear Dr. Arin,

Thank you for submitting your manuscript to PLOS One. After careful consideration, we feel that it has merit but does not fully meet PLOS One’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

==============================

Please submit your revised manuscript by Oct 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS One offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Silvia Fiorelli

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 in your text; if accepted, production will need this reference to link the reader to the Table.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

Reviewer #1: Well written protocol

Well written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocolWell written protocol9

Reviewer #2: This is a well-designed systematic review adhering to the PRISMA-P protocol and registered with PROSPERO. It addresses an important clinical question.

I note the authors have made reference to the limits that may be possible with meta-analysis. My main concern is that there may be a number of trials comparing differing airway techniques, which fails to provide a baseline control for comparative studies (eg studies comparing a videolaryngoscope to direct laryngoscopy versus studies comparing different laryngoscopes) and comparison across techniques may not be straightforward. It is also common in airway studies for different primary and secondary outcomes to be used, again which the authors refer to, but which may be methodologically limiting.

It may be also worth consideration that many measured outcomes may not be fully useful in describing airway management effectiveness (for example, if one intervention has a mean time to intubation of 65 seconds but a 90% success rate compared to neither with a mean time of 50 seconds, but only a 65% success rate, comparison is complex) and some discussion of how this will be accounted for would be worthwhile.

Reviewer #3: Dear Authors,

Your basic question is appropriate to improve the difficulties in the anaesthetic management of children with cleft lip and/or palate. The methods seem to be correct for this job.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Istvan Batai

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Oct 27;21(10):e0361327. doi: 10.1371/journal.pone.0361327.r002

Author response to Decision Letter 1


29 Sep 2026

Response to Reviewers

Manuscript ID: PONE-D-26-43191

Title: Airway management and anaesthetic interventions for children with cleft lip and/or palate undergoing general anaesthesia: protocol for a systematic review and meta-analysis

Dear Dr. Silvia Fiorelli and Reviewers,

Thank you for the careful evaluation of our manuscript and for the constructive comments. We have revised the protocol in response to all points raised. Below is our point-by-point response. All changes are highlighted in the “Revised Manuscript with Track Changes” file. A clean version of the revised manuscript is also provided.

Journal Requirements

1. PLOS ONE style requirements

We have carefully reviewed the PLOS ONE formatting templates and revised the manuscript (title page, headings, spacing, and overall formatting) to ensure full compliance with the journal’s style requirements. In addition, the name of the reporting guideline for protocols has been corrected to “(PRISMA-P) 2015” (Methods: Study design and reporting framework).

2. Data Availability Statement

We have clarified our data-sharing plan. Upon completion of the systematic review, the study-level extraction dataset, risk-of-bias assessments, and data underlying any meta-analytic estimates will be made available as Supporting Information. The Data Availability Statement in the manuscript has been updated accordingly.

3. Reference to Table 1

We thank the editors for pointing this out. We have now explicitly referred to Table 1 in the main text (Search strategy section). The sentence now reads:

The detailed search terms and Medical Subject Heading (MeSH) strategies used are presented in Table 1.

4. Recommended citations

None of the reviewers recommended citation of specific additional works. No changes were required.

5. Reference list

We have carefully reviewed the reference list for completeness, accuracy, and currency. No retracted articles were identified. No changes to the reference list were required.

Reviewer #1

We thank Reviewer #1 for the positive assessment of the protocol.

Reviewer #2

We sincerely thank Reviewer #2 for the thoughtful and constructive comments regarding the methodological challenges of synthesising heterogeneous airway trials.

Comment:

The reviewer noted that many trials compare different airway techniques without a consistent baseline control, that primary and secondary outcomes often differ across studies, and that outcomes such as time to intubation and success rate can be complex to interpret together. The reviewer suggested discussion of how these issues will be handled.

Response:

We fully agree with these important points. In response, we have substantially strengthened the Data synthesis section to make our planned approach explicit:

• Studies will be grouped for quantitative synthesis only when interventions and comparators are judged sufficiently similar.

• Trials comparing different classes of devices without a shared control arm will not be pooled in a single pairwise meta-analysis.

• Where data allow, exploratory subgroup analyses by intervention category (e.g., videolaryngoscopy versus direct laryngoscopy, specific device designs, or anaesthetic strategies) will be considered.

• When quantitative synthesis is inappropriate because of clinical diversity, results will be presented narratively and in structured tables organised by intervention type and outcome.

• Continuous outcomes such as time to intubation will be interpreted jointly with dichotomous success-related outcomes (first-attempt success, number of attempts, and failed intubation). A shorter mean intubation time will not be interpreted in isolation if accompanied by lower success rates or higher complication rates.

• Network meta-analysis will not be undertaken because the evidence network is expected to be sparse, and trials without a shared comparator will not be combined.

• Time to intubation, success-related outcomes and airway complications will be tabulated side by side for each comparison, so that speed and success can be judged together.

• A corresponding sentence has been added to the limitations paragraph of the Discussion.

These additions directly address the reviewer’s concerns about heterogeneity of techniques, lack of a common baseline, and the clinical interpretation of time versus success outcomes. We believe the revised synthesis plan is now more transparent and methodologically robust.

Reviewer #3

We thank Reviewer #3 for the positive evaluation of the research question and methods.

We hope that the revisions satisfactorily address all comments. We remain grateful for the reviewers’ and editor’s time and expertise, which have improved the clarity and methodological rigour of this protocol.

Kind regards,

Kazi Mahzabin Arin

(on behalf of all co-authors)

Corresponding author

Department of Anaesthesia, Analgesia and Intensive Care Medicine

Bangladesh Medical University, Shahbag, Dhaka, Bangladesh

Email: kazimahzabinarin@bsmmu.edu.bd

Attachment

Submitted filename: Response to Reviwers.docx

pone.0361327.s002.docx (22KB, docx)

Decision Letter 1

Silvia Fiorelli

8 Oct 2026

Airway management and anaesthetic interventions for children with cleft lip and/or palate undergoing general anaesthesia: protocol for a systematic review and meta-analysis

PONE-D-26-43191R1

Dear Dr. Kazi Mahzabin Arin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Silvia Fiorelli

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??>

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??>

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

Reviewer #2: This was already a strong submission, and the additional modifications are more than satisfactory. The researchers should be commended on a robust methodology and addressing a clinically important question. I would strongly support publication.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

Acceptance letter

Silvia Fiorelli

PONE-D-26-43191R1

PLOS One

Dear Dr. Arin,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS One and supporting open access.

Kind regards,

PLOS One Editorial Office Staff

on behalf of

Dr. Silvia Fiorelli

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA-P 2015 checklist.

    (DOCX)

    pone.0361327.s001.docx (19.8KB, docx)
    Attachment

    Submitted filename: Response to Reviwers.docx

    pone.0361327.s002.docx (22KB, docx)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES